Phased review by EMA aims to accelerate assessment of company's investigational drug daraxonrasib in pancreatic cancer based on unprecedented clinical results from pivotal Phase 3 RASolute 302 ...
Upcoming Type B Statistical Methods Meeting expected to set stage for FDA to align with EMA and MHRA on use of Fall 2026 ...
The Federal Government launches phase two of the TVET programme, enhancing skills for young Nigerians, boosting employability ...
This secular, queer friendly addiction recovery group presents July opportunities. A weekly support group meets every Monday ...
A new common application for Nevada Ready! pre-K programs is now available, giving families a single pathway to apply to more than 90 participating pre-K programs across the state. The application was ...
The Securities and Exchange Commission (SEC) is proposing to make significant changes to the eligibility of issuers to utilize Securities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results